Related Experiment Video
Updated: Jul 19, 2025

08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.1K
Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and
Molecular Pharmaceutics
|August 10, 2023
Summary
Messenger RNA (mRNA) therapies offer advantages over traditional gene modification. Coacervate delivery systems show promise for enhancing mRNA therapeutics by protecting against degradation and improving cellular uptake.
Area of Science:
- Biotechnology and Pharmaceutical Sciences
- Drug Delivery Systems
- Molecular Biology
Background:
- Messenger RNA (mRNA)-based therapies have gained prominence, particularly after COVID-19 vaccine development.
- mRNA therapies offer advantages like reduced genetic mutation risk, controlled gene expression, and rapid production.
- Existing non-viral vectors face limitations in efficiency, safety, and stability for mRNA delivery.
Purpose of the Study:
- To review the limitations of current mRNA delivery strategies.
- To highlight the potential of coacervate-based systems for mRNA delivery.
- To provide a comprehensive overview of coacervate-mediated mRNA delivery.
Main Methods:
- Review of existing literature on mRNA delivery systems.
- Analysis of coacervate properties and their application in drug delivery.
- Exploration of coacervating agents and their impact on mRNA encapsulation, stability, and release.
Main Results:
- Coacervates offer protection against mRNA degradation and enhance cellular uptake.
- Coacervate-based systems facilitate sustained and controlled gene expression.
- Coacervates demonstrate potential for targeted delivery of mRNA therapeutics.
Conclusions:
- Coacervate-based delivery systems are a promising strategy to overcome current challenges in mRNA therapeutics.
- Further research into coacervate-mediated delivery is needed to fully realize its potential in gene therapy and drug delivery.
- Coacervates can enable groundbreaking applications in RNA therapeutics.
Related Concept Videos
Regulated mRNA Transport
2.8K
2.8K
COP Coated Vesicles
7.9K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
7.9K
Nuclear Export of mRNA
7.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K
Cotranslational Protein Translocation
7.4K
Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
7.4K
Directing Proteins to the Rough Endoplasmic Reticulum
7.3K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
7.3K
Clathrin Coated Vesicles
7.1K
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
7.1K

